Clinical Study
Evaluation of Rhubarb Supplementation in Stages 3 and 4 of Chronic Kidney Disease: A Randomized Clinical Trial
Table 3
Comparison of adverse drug reactions (ADRs) between control and Rhubarb group.
| Serial
number | ADR recorded | Control
() | Rhubarb
() | Significance
(2-tailed) |
| | 1 | Nausea | 5 | 4 | 0.494 | | 2 | Vomiting | 4 | 3 | 0.442 | | 3 | Diarrhea | 5 | 3 | 0.275 | | 4 | Constipation | 0 | 1 | 0.497 | | 5 | Anorexia | 4 | 2 | 0.719 | | 6 | Excessive thirst | 0 | 1 | 0.245 | | 7 | Abdominal pain | 1 | 1 | 1.000 | | 8 | Muscle and joint pain | 0 | 1 | 1.000 | | 9 | Headache | 3 | 2 | 0.366 | | 10 | Rashes | 0 | 2 | 1.000 | | 11 | Altered taste | 0 | 1 | 1.000 | | 12 | Weakness | 1 | 0 | 0.497 | | 13 | Frequent urination | 0 | 2 | 1.000 |
|
|
was considered significant. Fisher’s exact test was applied.
|
